Recently, Han et al. [110] have reported that resibufogenin was shown to suppress the growth and metastasis of colorectal cancer by inducing RIPK3 necroptosis both in vitro and in vivo ﻿through upregulating RIPK3 and MLKL protein at Ser358. The gene discussed is RIPK3; the disease is colorectal cancer.